Tag #Pharmaceutical Investment

Showing 1 to 4 of 4 results

bbc.com

🌐 85% Global Worthiness

Sep 25, 04:17

UK Medicine Prices Must Rise to Attract Pharmaceutical Investment, Says Science Minister

Science minister Patrick Vallance says the UK must raise NHS medicine prices to prevent pharmaceutical companies from pulling investment from the country, following recent project cancellations by major drugmakers.

UK Medicine Prices Must Rise to Attract Pharmaceutical Investment, Says Science Minister

Science minister Patrick Vallance says the UK must raise NHS medicine prices to prevent pharmaceutical companies from pulling investment from the country, following recent project cancellations by major drugmakers.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary reason for the proposed increase in NHS medicine prices?

To attract and retain pharmaceutical investment in the UK. Several major drug companies have recently cancelled or paused UK projects due to low drug prices, lack of government investment, and international price pressures. Price increases are deemed necessary to reverse this trend.

thetimes.com

🌐 85% Global Worthiness

Jul 22, 10:12

AstraZeneca's $50 Billion US Investment, Sizewell C Approval, and UK Borrowing Surge

AstraZeneca will invest $50 billion in US facilities by 2030 due to President Trump's tariffs; the UK approved the Sizewell C nuclear plant costing £38 billion; June government borrowing reached £20.7 billion, exceeding forecasts.

AstraZeneca's $50 Billion US Investment, Sizewell C Approval, and UK Borrowing Surge

AstraZeneca will invest $50 billion in US facilities by 2030 due to President Trump's tariffs; the UK approved the Sizewell C nuclear plant costing £38 billion; June government borrowing reached £20.7 billion, exceeding forecasts.

Progress

32% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What are the long-term implications of President Trump's tariff policy on pharmaceutical manufacturing and global investment flows?

AstraZeneca's significant US investment highlights the impact of trade policy on pharmaceutical manufacturing location. The UK's substantial investment in Sizewell C, coupled with rising government debt, suggests a long-term strategic bet on nuclear energy amidst fiscal constraints. Subdued Asian markets reflect global uncertainty surrounding US trade negotiations.

theguardian.com

🌐 85% Global Worthiness

Sep 24, 13:21

Eli Lilly CEO Calls UK "Worst in Europe" for Drug Prices, Threatening Investment

Eli Lilly's CEO, Dave Ricks, criticized the UK's drug pricing regime as the "worst in Europe," citing it as a reason for the pharmaceutical industry's withdrawal of nearly £2 billion in planned investments.

Eli Lilly CEO Calls UK "Worst in Europe" for Drug Prices, Threatening Investment

Eli Lilly's CEO, Dave Ricks, criticized the UK's drug pricing regime as the "worst in Europe," citing it as a reason for the pharmaceutical industry's withdrawal of nearly £2 billion in planned investments.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of the UK's drug pricing policies on pharmaceutical investment and new drug availability?

Pharmaceutical companies, including Eli Lilly, have withdrawn approximately £2 billion in planned UK investments this year due to the UK's strict pricing regime. This policy may lead to reduced availability of new drugs in the UK.

theguardian.com

🌐 85% Global Worthiness

Feb 3, 22:11

AstraZeneca Cancels £450m UK Vaccine Plant Expansion

AstraZeneca scrapped a £450 million UK vaccine plant expansion due to a reduced government funding offer following a change in planned research and development investment, disappointing the UK science minister and impacting 450 jobs.

AstraZeneca Cancels £450m UK Vaccine Plant Expansion

AstraZeneca scrapped a £450 million UK vaccine plant expansion due to a reduced government funding offer following a change in planned research and development investment, disappointing the UK science minister and impacting 450 jobs.

Progress

44% Bias Score

ShareSaveArticle

Industry, Innovation, and Infrastructure

12345678

Previous 1 of 8 Next

What are the immediate consequences of AstraZeneca's decision to cancel the Merseyside vaccine plant expansion?

AstraZeneca cancelled a £450 million expansion of its Merseyside vaccine plant, disappointing the UK science minister. The company cited a reduced government offer compared to a previous proposal, resulting in a smaller planned UK research and development investment. This decision impacts UK research and development and jobs.

Showing 1 to 4 of 4 results